Harrison S - Search Results

1

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Among authors: harrison s. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.

2

Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Harrison SA, et al. Arch Pathol Lab Med. 2006 Jan;130(1):27-32. doi: 10.5858/2006-130-27-DHDMOT. Arch Pathol Lab Med. 2006. PMID: 16390234 Free article.

3

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

4

Current treatments in nonalcoholic steatohepatitis.

Torres DM, Harrison SA. Torres DM, et al. Curr Treat Options Gastroenterol. 2007 Dec;10(6):425-34. doi: 10.1007/s11938-007-0042-y. Curr Treat Options Gastroenterol. 2007. PMID: 18221603

5

Diagnosis and therapy of nonalcoholic steatohepatitis.

Torres DM, Harrison SA. Torres DM, et al. Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077. Gastroenterology. 2008. PMID: 18471547 Review.

6

HCV replication and statin pleotropism: an adjuvant treatment panacea?

Torres DM, Harrison SA. Torres DM, et al. Am J Gastroenterol. 2008 Jun;103(6):1390-2. doi: 10.1111/j.1572-0241.2008.01881.x. Epub 2008 May 13. Am J Gastroenterol. 2008. PMID: 18479495

7

Insulin resistance in chronic hepatitis C, genotypes 1 and 4: the unfortunate reality.

Torres DM, Harrison SA. Torres DM, et al. Hepatology. 2008 Jun;47(6):2137-9. doi: 10.1002/hep.22353. Hepatology. 2008. PMID: 18508298 No abstract available.

8

Current and emerging therapies in nonalcoholic fatty liver disease.

Kashi MR, Torres DM, Harrison SA. Kashi MR, et al. Semin Liver Dis. 2008 Nov;28(4):396-406. doi: 10.1055/s-0028-1091984. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956296 Review.

9

A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. Nelson A, et al. J Clin Gastroenterol. 2009 Nov-Dec;43(10):990-4. doi: 10.1097/MCG.0b013e31819c392e. J Clin Gastroenterol. 2009. PMID: 19448566 Clinical Trial.

10

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Gastaldelli A, et al. Among authors: harrison sa. Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116. Hepatology. 2009. PMID: 19670459 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,466 results

Search Page

Filters